Richard Bernstein Advisors LLC Sells 2,449 Shares of Regeneron Pharmaceuticals, Inc. $REGN

Richard Bernstein Advisors LLC reduced its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 65% in the third quarter, selling 2,449 shares. Insiders, including SVP Jason Pitofsky, have also been selling shares, totaling $4.14 million in sales over the last 90 days. Despite the institutional selling, analysts maintain a “Moderate Buy” rating with an average price target of $802.27 for Regeneron.